Zoetis (ZTS) Common Equity (2012 - 2026)
Zoetis (ZTS) reported Common Equity of $3.2 billion for Q1 2026, down 33.55% year-over-year from $4.9 billion in Q1 2025, and down 5.33% quarter-over-quarter from $3.4 billion in Q4 2025.
Zoetis (ZTS) Common Equity (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has 15 years of Common Equity data on file, last reported at $3.2 billion in Q1 2026.
- Common Equity for Q1 2026 came in at $3.2 billion, down 33.55% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.2 billion (down 33.55% YoY), and the FY2025 annual result was $3.4 billion, down 29.5% from the prior year.
- Common Equity fell to $3.2 billion in Q1 2026 per ZTS's latest filing, from $3.4 billion in the prior quarter.
- Over five years, Common Equity peaked at $5.4 billion in Q3 2025 and troughed at $3.2 billion in Q1 2026.
- A 5-year average of $4.7 billion and a median of $4.8 billion in 2024 frame the typical range for Common Equity.
- The sharpest annual moves came in 2022 and 2026: Common Equity grew 13.83% in 2022, then tumbled 33.55% in 2026.
- A 5-year view of Common Equity shows it stood at $4.4 billion in 2022, then increased by 13.35% to $5.0 billion in 2023, then dropped by 2.95% to $4.8 billion in 2024, then fell by 29.5% to $3.4 billion in 2025, then retreated by 5.33% to $3.2 billion in 2026.
- Business Quant data shows ZTS's Common Equity at $3.2 billion in Q1 2026, $3.4 billion in Q4 2025, and $5.4 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 8.23 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 3.23 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 5.90 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 407.18 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 3.41 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 6.50 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 1.75 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.21 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 446.17 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 108.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.23 Bn |
| Dec 31, 2025 | 3.42 Bn |
| Sep 30, 2025 | 5.40 Bn |
| Jun 30, 2025 | 4.98 Bn |
| Mar 31, 2025 | 4.87 Bn |
| Dec 31, 2024 | 4.84 Bn |
| Sep 30, 2024 | 5.23 Bn |
| Jun 30, 2024 | 4.96 Bn |
| Mar 31, 2024 | 5.05 Bn |
| Dec 31, 2023 | 4.99 Bn |
| Sep 30, 2023 | 5.07 Bn |
| Jun 30, 2023 | 4.62 Bn |
| Mar 31, 2023 | 4.49 Bn |
| Dec 31, 2022 | 4.40 Bn |
| Sep 30, 2022 | 4.66 Bn |
| Jun 30, 2022 | 4.58 Bn |
| Mar 31, 2022 | 4.66 Bn |
| Dec 31, 2021 | 4.54 Bn |
| Sep 30, 2021 | 4.68 Bn |
| Jun 30, 2021 | 4.35 Bn |